SCHEMBL3277152

SCHEMBL3277152

Pc1cccc(Cl)c1-c1cccc2ccccc12

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 4/20 0.54
CYP1A2 P05177 4/20 0.54
TYMP P19971 1/20 0.46
RORC P51449 1/20 0.40
RORB Q92753 1/20 0.40
DHFR P00374 1/20 0.40
KDM4E B2RXH2 2/20 0.39
ALDH1A1 P00352 2/20 0.39
HSD17B10 Q99714 2/20 0.39
CYP2C19 P33261 1/20 0.39
RAB9A P51151 1/20 0.39
ATM Q13315 1/20 0.39
MAPT P10636 1/20 0.38
PTPN1 P18031 1/20 0.36
ALPL P05186 1/20 0.36
GAA P10253 1/20 0.36
TSHR P16473 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
GUSB P08236 1/20 0.36
CYP1A1 P04798 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30424976 0.80 CYP2A6 (0.54) CYP2A6CYP1A2TYMPRORCRORB
SCHEMBL7637791 0.79 CYP1A2 (0.52) CYP2A6CYP1A2TYMPRORCRORB
SCHEMBL24758930 0.79 CYP2A6 (0.52) CYP2A6CYP1A2TYMPRORCRORB
SCHEMBL367587 0.78 DNMT1 (0.47) CYP2A6CYP1A2TYMPDHFRKDM4E
SCHEMBL30944688 0.78 DNMT1 (0.47) CYP2A6CYP1A2TYMPDHFRKDM4E
SCHEMBL365419 0.77 ALDH1A1 (0.43) CYP2A6CYP1A2KDM4EALDH1A1HSD17B10
SCHEMBL30866412 0.77 CYP2A6 (0.65) CYP2A6CYP1A2TYMPRORCRORB
SCHEMBL9770068 0.77 CYP2A6 (0.65) CYP2A6CYP1A2TYMPRORCRORB
SCHEMBL6035360 0.77 CYP1A2 (0.44) CYP2A6CYP1A2TYMPRORCRORB
SCHEMBL4268573 0.77 CYP2A6 (0.48) CYP2A6CYP1A2TYMPRORCRORB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7696349-B2 Method for asymmetric synthesis BASF SE (DE) 2010-04-13 US disclosed
US-20090326226-A1 METHOD FOR ASYMMETRIC SYNTHESIS BASF AKTIENGESELLSCHAFT (DE) 2009-12-31 US disclosed
US-7442842-B2 Method for asymmetric synthesis BASF SE (DE) 2008-10-28 US disclosed
US-20070073092-A1 Method for asymmetric synthesis BASF AKTIENGESELLSCHAFT (DE) 2007-03-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070073092-A1 Method for asymmetric synthesis COASY, PIN1, INF2 CYP2A6 31/4885CYP1A2 127/4885TYMP 1016/4885
US-20090326226-A1 METHOD FOR ASYMMETRIC SYNTHESIS COASY, PIN1, INF2 CYP2A6 31/4885CYP1A2 127/4885TYMP 1016/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.